Pubblicazioni

Autori:

Zucchini, Stefano; Tumini, Stefano; Scaramuzza, Andrea Enzo; Bonfanti, Riccardo; Delvecchio, Maurizio; Franceschi, Roberto; Iafusco, Dario; Lenzi, Lorenzo; Mozzillo, Enza; Passanisi, Stefano; Piona, Claudia; Rabbone, Ivana; Rapini, Novella; Rigamonti, Andrea; Ripoli, Carlo; Salzano, Giuseppina; Savastio, Silvia; Schiaffini, Riccardo; Zanfardino, Angela; Cherubini, Valentino

Titolo:

Recommendations for recognizing, risk stratifying, treating, and managing children and adolescents with hypoglycemia

Anno:

2024

Tipologia prodotto:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Lingua:

Inglese

Referee:

No

Nome rivista:

FRONTIERS IN ENDOCRINOLOGY

ISSN Rivista:

1664-2392

N° Volume:

15

Intervallo pagine:

1387537-1387550

Parole chiave:

adolescents; automated insulin delivery; children; glucagon; hypoglycemia; oral glucose; type 1 diabetes

Breve descrizione dei contenuti:

There has been continuous progress in diabetes management over the last few decades, not least due to the widespread dissemination of continuous glucose monitoring (CGM) and automated insulin delivery systems. These technological advances have radically changed the daily lives of people living with diabetes, improving the quality of life of both children and their families. Despite this, hypoglycemia remains the primary side-effect of insulin therapy. Based on a systematic review of the available scientific evidence, this paper aims to provide evidence-based recommendations for recognizing, risk stratifying, treating, and managing patients with hypoglycemia. The objective of these recommendations is to unify the behavior of pediatric diabetologists with respect to the timely recognition and prevention of hypoglycemic episodes and the correct treatment of hypoglycemia, especially in patients using CGM or advanced hybrid closed-loop systems. All authors have long experience in the specialty and are members of the Italian Society of Pediatric Endocrinology and Diabetology. The goal of treating hypoglycemia is to raise blood glucose above 70 mg/dL (3.9 mmol/L) and to prevent further decreases. Oral glucose at a dose of 0.3 g/kg (0.1 g/kg for children using "smart pumps" or hybrid closed loop systems in automated mode) is the preferred treatment for the conscious individual with blood glucose <70 mg/dL (3.9 mmol/L), although any form of carbohydrate (e.g., sucrose, which consists of glucose and fructose, or honey, sugary soft drinks, or fruit juice) containing glucose may be used. Using automatic insulin delivery systems, the oral glucose dose can be decreased to 0.1 g/kg. Practical flow charts are included to aid clinical decision-making. Although representing the official position of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED), these guidelines are applicable to the global audience and are especially pertinent in the era of CGM and other advanced technologies.

Id prodotto:

142052

Handle IRIS:

11562/1144161

ultima modifica:

30 ottobre 2024

Citazione bibliografica:

Zucchini, Stefano; Tumini, Stefano; Scaramuzza, Andrea Enzo; Bonfanti, Riccardo; Delvecchio, Maurizio; Franceschi, Roberto; Iafusco, Dario; Lenzi, Lorenzo; Mozzillo, Enza; Passanisi, Stefano; Piona, Claudia; Rabbone, Ivana; Rapini, Novella; Rigamonti, Andrea; Ripoli, Carlo; Salzano, Giuseppina; Savastio, Silvia; Schiaffini, Riccardo; Zanfardino, Angela; Cherubini, Valentino, Recommendations for recognizing, risk stratifying, treating, and managing children and adolescents with hypoglycemia «FRONTIERS IN ENDOCRINOLOGY» , vol. 15 , 2024 , pp. 1387537-1387550

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo